Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors

por Huang, Nana, Zhao, Chenchen, Hu, Xueyang, Zhang, Congjun, Xiong, Fuxing, Huang, Wei, Da, Liangshan, Shen, Yuanyuan, Wu, Hongyang
Publicado 2022

Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a retrospective cohort

por Wu, Hongyang, Huang, Nana, Zhao, Chenchen, Hu, Xueyang, Da, Liangshan, Huang, Wei, Shen, Yuanyuan, Xiong, Fuxing, Zhang, Congjun
Publicado 2022